Patents by Inventor Saburo Uchikuga

Saburo Uchikuga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5601806
    Abstract: Taurine analogues are used for scavenging active oxygen compounds and preventing and minimizing damage to the skin from ultraviolet rays. The taurine analogues have the following formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are as defined in the specification.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: February 11, 1997
    Assignee: Sogo Pharmaceutical Company Limited
    Inventors: Manabu Katsumata, Keiko Kiuchi, Tomoyasu Tashiro, Saburo Uchikuga
  • Patent number: 4898870
    Abstract: The present invention concerns an enzyme inhibitor containing the compound represented by the following formula (I) as an effective ingredient: ##STR1## where R represents hydrogen or substituted or not substituted alkyl group, alkenyl group, aryl group or aralkyl group, X represents OR' or NR"R"', in which R', R" and R'" represent respectively hydrogen or substituted or not substituted alkyl group, alkenyl group, aryl group or aralkyl group.The enzyme inhibitor according to the present invention can effectively inhibit aldose reductase, glyoxalase I and reverse transcriptase.
    Type: Grant
    Filed: January 19, 1989
    Date of Patent: February 6, 1990
    Assignee: Sogo Pharmaceutical Company Limited
    Inventors: Yuji Narutomi, Manabu Katsumata, Yasuko Osawa, Saburo Uchikuga
  • Patent number: 4413129
    Abstract: Cimetidine, namely N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl) methylthio) ethyl] guanidine which is useful as an antagonist of H.sub.2 -receptor is prepared by reacting 4-methyl-5-[(2-aminoethyl) thiomethyl] imidazole, which is obtained by the reaction of 4-methyl-5-hydroxymethylimidazole on 2-aminoethanethiolsulfuric acid, with O-alkyl-S-alkyl-cyanothioimidocarbonate to give N-cyano-N'-[2-((4-methyl-5-imidazolyl) methylthio) ethyl]-O-alkylisourea, which is reacted with monomethylamine. According to the present process, cimetidine can be prepared in good yield and desired purity with very reduced amount of methyl mercaptan released from the reaction.
    Type: Grant
    Filed: January 17, 1980
    Date of Patent: November 1, 1983
    Assignee: Sogo Pharmaceutical Company, Ltd.
    Inventors: Saburo Uchikuga, Tomoyasu Tashiro, Yasuko Osawa
  • Patent number: 4374247
    Abstract: A method for preparing 2,2-disubstituted thiazolidine involves reacting aminoalkyl hydrogen-sulfate with a compound having hydrosulfide ion in the presence of ketone. According to the present method, such thiazolidine can be prepared in good yield and desired purity without using harmful ethylenimine as a starting material.
    Type: Grant
    Filed: June 4, 1980
    Date of Patent: February 15, 1983
    Assignee: Sogo Pharmaceutical Co., Ltd.
    Inventors: Yasuko Osawa, Saburo Uchikuga
  • Patent number: 4371472
    Abstract: A process for preparing a cysteamine-S-substituted compound involves reacting ethyleneimine or ethyleneimine derivatives with a thiosulfate or thiophosphate in the presence of a cation exchanger of a free type. Use of the cation exchanger of a free type in this reaction allows preparation of the cysteamine-S-substituted compound with an amazingly high purity in a high yield.
    Type: Grant
    Filed: February 3, 1981
    Date of Patent: February 1, 1983
    Assignee: Sogo Pharmaceutical Co. Ltd.
    Inventors: Tethuharu Okazaki, Takeo Komukai, Saburo Uchikuga
  • Patent number: 4250109
    Abstract: Hexamethylene.bis-dicyandiamide is safely prepared in good yield and desired purity by a novel method which comprises reacting N-cyano-O (or S)-alkyl-iso (or isothio) urea with hexamethylenediamine. The desired product is useful as an intermediate of chlorhexidine which is an antibacterial agent.
    Type: Grant
    Filed: August 7, 1979
    Date of Patent: February 10, 1981
    Assignee: Sogo Pharmaceutical Company Limited
    Inventors: Saburo Uchikuga, Michiro Itoh, Katsuyasu Nagahama
  • Patent number: 4060551
    Abstract: Salt of pantothenic acid and salt of cystamine or cysteamine are caused to react under the presence of an accelerator selected from the group consisting of carbodiimides and N-hydroxy compounds without any pretreatment thereby producing pantethine or pantetheine, and the pantetheine is oxidized to produce pantethine which is a precursor of co-enzyme A.
    Type: Grant
    Filed: August 10, 1976
    Date of Patent: November 29, 1977
    Assignee: Sogo Pharmaceutical Company Limited
    Inventors: Saburo Uchikuga, Masataka Kuroki